Literature DB >> 1628306

Immunocytochemical localization of collagen types I, III, IV, and fibronectin in the human dermis. Modifications with ageing.

L Vitellaro-Zuccarello1, R Garbelli, V D Rossi.   

Abstract

The distribution of collagen types I, III, IV, and of fibronectin has been studied in the human dermis by light and electron-microscopic immunocytochemistry, using affinity purified primary antibodies and tetramethylrhodamine isothiocyanate-conjugated secondary antibodies. Type I collagen was present in all collagen fibers of both papillary and reticular dermis, but collagen fibrils, which could be resolved as discrete entities, were labeled with different intensity. Type III collagen codistributed with type I in the collagen fibers, besides being concentrated around blood vessels and skin appendages. Coexistence of type I and type III collagens in the collagen fibrils of the whole dermis was confirmed by ultrastructural double-labelling experiments using colloidal immunogold as a probe. Type IV collagen was detected in all basement membranes. Fibronectin was distributed in patches among collagen fibers and was associated with all basement membranes, while a weaker positive reaction was observed in collagen fibers. Ageing caused the thinning of collagen fibers, chiefly in the reticular dermis. The labeling pattern of both type I and III collagens did not change in skin samples from patients of up to 79 years of age, but immunoreactivity for type III collagen increased in comparison to younger skins. A loss of fibronectin, likely related to the decreased morphogenetic activity of tissues, was observed with age.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1628306     DOI: 10.1007/bf00319157

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  34 in total

1.  Distribution of type I and type III collagen in the developing periodontal ligament of mice.

Authors:  Y H Huang; Y Ohsaki; K Kurisu
Journal:  Matrix       Date:  1991-02

2.  Reevaluation of fibronectin-collagen interactions in tissues: an immunocytochemical and immunochemical study.

Authors:  A J Cidadão; S Thorsteinsdóttir; J F David-Ferreira
Journal:  J Histochem Cytochem       Date:  1988-06       Impact factor: 2.479

3.  Immunofluorescent localization of type I and III collagens in normal human skin with polyclonal and monoclonal antibodies.

Authors:  K Fukai; M Ishii; M Chanoki; H Kobayashi; T Hamada; Y Muragaki; A Ooshima
Journal:  Acta Derm Venereol       Date:  1988       Impact factor: 4.437

4.  A pre-embedding immunolabeling technique for basal lamina and extracellular matrix molecules.

Authors:  M M Martins-Green; K T Tokuyasu
Journal:  J Histochem Cytochem       Date:  1988-04       Impact factor: 2.479

5.  (Alpha1(3))3 human skin collagen. Release by pepsin digestion and preponderance in fetal life.

Authors:  E H Epstein
Journal:  J Biol Chem       Date:  1974-05-25       Impact factor: 5.157

6.  Estimation of types I and III collagens in whole tissue by quantitation of CNBr peptides on SDS-polyacrylamide gels.

Authors:  N D Light
Journal:  Biochim Biophys Acta       Date:  1982-03-18

7.  Ultrastructural localization of fibronectin to different anatomic structures of human skin.

Authors:  R Fleischmajer; R Timpl
Journal:  J Histochem Cytochem       Date:  1984-03       Impact factor: 2.479

8.  Biochemical investigations of different forms of osteogenesis imperfecta. Evaluation of 44 cases.

Authors:  G Cetta; G De Luca; R Tenni; G Zanaboni; L Lenzi; A A Castellani
Journal:  Connect Tissue Res       Date:  1983       Impact factor: 3.417

9.  Studies on fibronectin in the skin. I. Indirect immunofluorescence studies in normal human skin.

Authors:  O Fyrand
Journal:  Br J Dermatol       Date:  1979-09       Impact factor: 9.302

10.  Distribution of immunoreactive fibronectin and collagen (type I, III, IV) in mouse joints. Fibronectin, an essential component of the synovial cavity border.

Authors:  G Linck; S Stocker; J A Grimaud; A Porte
Journal:  Histochemistry       Date:  1983
View more
  8 in total

1.  Static and dynamic fibroblast seeding and cultivation in porous PEO/PBT scaffolds.

Authors:  Y L Xiao; J Riesle; C A Van Blitterswijk
Journal:  J Mater Sci Mater Med       Date:  1999-12       Impact factor: 3.896

2.  Circular permutation directs orthogonal assembly in complex collagen peptide mixtures.

Authors:  Fei Xu; Teresita Silva; Mihir Joshi; Sohail Zahid; Vikas Nanda
Journal:  J Biol Chem       Date:  2013-09-16       Impact factor: 5.157

Review 3.  The effects of ageing on cutaneous wound healing in mammals.

Authors:  G S Ashcroft; M A Horan; M W Ferguson
Journal:  J Anat       Date:  1995-08       Impact factor: 2.610

4.  Age related changes in the non-collagenous components of the extracellular matrix of the human lamina cribrosa.

Authors:  J Albon; W S Karwatowski; D L Easty; T J Sims; V C Duance
Journal:  Br J Ophthalmol       Date:  2000-03       Impact factor: 4.638

5.  Immunohistochemical localization of laminin and type IV collagen in human cutaneous sensory nerve formations.

Authors:  J A Vega; I Esteban; F J Naves; M E del Valle; L Malinovsky
Journal:  Anat Embryol (Berl)       Date:  1995-01

6.  Distribution of extracellular matrix components in nuchal skin from fetuses carrying trisomy 18 and trisomy 21.

Authors:  B Brand-Saberi; H H Epperlein; G E Romanos; B Christ
Journal:  Cell Tissue Res       Date:  1994-09       Impact factor: 5.249

7.  The human optic nerve: fascicular organisation and connective tissue types along the extra-fascicular matrix.

Authors:  G Jeffery; A Evans; J Albon; V Duance; J Neal; G Dawidek
Journal:  Anat Embryol (Berl)       Date:  1995-06

8.  Hydrolyzed eggshell membrane immobilized on phosphorylcholine polymer supplies extracellular matrix environment for human dermal fibroblasts.

Authors:  Eri Ohto-Fujita; Tomohiro Konno; Miho Shimizu; Kazuhiko Ishihara; Toshihiro Sugitate; Jun Miyake; Kotaro Yoshimura; Kaori Taniwaki; Takashi Sakurai; Yukio Hasebe; Yoriko Atomi
Journal:  Cell Tissue Res       Date:  2011-05-20       Impact factor: 5.249

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.